(Q35011992)

5 August 2017

title

Physician patterns of metabolic screening for patients taking atypical antipsychotics: a retrospective database study (English)

1 reference

5 August 2017

Charles Motsinger

1

1 reference

5 August 2017

Michael Slack

series ordinal

2

1 reference

5 August 2017

Melanie Weaver

series ordinal

3

1 reference

5 August 2017

Morgan Reed

series ordinal

4

1 reference

5 August 2017

publication date

1 January 2006

1 reference

Primary Care Companion to the Journal of Clinical Psychiatry

5 August 2017

published in

1 reference

5 August 2017

volume

8

1 reference

5 August 2017

issue

4

1 reference

5 August 2017

page(s)

220-223

1 reference

Modern antipsychotic drugs: a critical overview

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1557474

Metabolic issues and cardiovascular disease in patients with psychiatric disorders

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1557474

Consensus development conference on antipsychotic drugs and obesity and diabetes

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1557474

Understanding the new and evolving profile of adverse drug effects in schizophrenia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1557474

Clinical use of quetiapine in disease states other than schizophrenia.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1557474

Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1557474

Practice parameter: Management of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1557474

Augmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder using adjunctive olanzapine: a placebo-controlled trial.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1557474

Treatment of borderline personality disorder with risperidone

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1557474

25 October 2018

Identifiers

DOI

10.4088/PCC.V08N0405

1 reference

5 August 2017

1 reference

5 August 2017

1 reference